Mapping Keratoconus Molecular Substrates by Multiplexed High-Resolution Proteomics of Unpooled Corneas.

Keratoconus (KCN) is a leading cause for cornea grafting worldwide. Keratoconus is a multifactorial disease that causes progressive thinning of the cornea and whose etiology is poorly understood. Several studies have used proteomics on patient tear fluids to identify potential biomarkers. However, proteome of the cornea itself has not been investigated fully. We report here new findings from a case-control study using multiplexed mass spectrometry (MS) on individual (unpooled) corneas to gain deeper insights into proteins and biomarkers relevant to keratoconus. We employed a high-pressure approach to extract total protein from individual corneas from five cases and five controls, followed by trypsin digestion and tandem mass tag (TMT) labeling. The MS-derived data were searched using the Human NCBI RefSeq protein database v92, with peptides and proteins filtered at 1% false discovery rate. A total of 3132 proteins were detected, of which 627 were altered significantly (p ≤ 0.05) in keratoconus corneas. The increases were overwhelmingly in the mTOR/PI3/AKT signal-mediated regulations of cell survival and proliferation, nonsense-mediated decay of transcripts, and proteasomal pathways. The decreases were in several extracellular matrix proteins and in many members of the complement system. Importantly, this multiplexed proteomic study of keratoconus corneas identified, to our knowledge, the largest number of corneal proteins. The novel findings include changes in pathways that regulate transcript stability, proteasomal degradation, and the complement system in corneas with keratoconus. These observations offer new prospects toward future discovery of novel molecular targets for diagnostic and therapeutic innovations for patients with keratoconus.

[1]  L. Maquat,et al.  Quality and quantity control of gene expression by nonsense-mediated mRNA decay , 2019, Nature Reviews Molecular Cell Biology.

[2]  J. Mehta,et al.  Differential epithelial and stromal protein profiles in cone and non-cone regions of keratoconus corneas , 2019, Scientific Reports.

[3]  J. Chen,et al.  ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay , 2018, Proceedings of the National Academy of Sciences.

[4]  Tibor Juhasz,et al.  Axial mechanical and structural characterization of keratoconus corneas , 2018, Experimental eye research.

[5]  A. Al-Amri Prevalence of Keratoconus in a Refractive Surgery Population , 2018, Journal of ophthalmology.

[6]  A. Pandey,et al.  Integrated Stress Response and Decreased ECM in Cultured Stromal Cells From Keratoconus Corneas , 2018, Investigative ophthalmology & visual science.

[7]  F. Hafezi,et al.  Prevalence of keratoconus in paediatric patients in Riyadh, Saudi Arabia , 2018, British Journal of Ophthalmology.

[8]  A. Jun,et al.  Pathophysiology of Keratoconus: What Do We Know Today , 2017, The open ophthalmology journal.

[9]  M. Wilkinson,et al.  Stress and the nonsense-mediated RNA decay pathway , 2017, Cellular and Molecular Life Sciences.

[10]  J. Frydman,et al.  Protein misfolding in neurodegenerative diseases: implications and strategies , 2017, Translational Neurodegeneration.

[11]  Mila Ljujic,et al.  The integrated stress response , 2016, EMBO reports.

[12]  Randal J. Kaufman,et al.  Protein misfolding in the endoplasmic reticulum as a conduit to human disease , 2016, Nature.

[13]  A. Pandey,et al.  Activating Mutations in PIK3CA Lead to Widespread Modulation of the Tyrosine Phosphoproteome. , 2015, Journal of proteome research.

[14]  S. Gill,et al.  The role of TIMPs in regulation of extracellular matrix proteolysis. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[15]  Ling Chen,et al.  Fibulin1C peptide induces cell attachment and extracellular matrix deposition in lung fibroblasts , 2015, Scientific Reports.

[16]  Xuejun Wang,et al.  The COP9 signalosome and cullin-RING ligases in the heart. , 2015, American journal of cardiovascular disease.

[17]  J. Asara,et al.  Gross Cystic Disease Fluid Protein-15/Prolactin-Inducible Protein as a Biomarker for Keratoconus Disease , 2014, PloS one.

[18]  A. Koromilas,et al.  Translational Control during Endoplasmic Reticulum Stress beyond Phosphorylation of the Translation Initiation Factor eIF2α* , 2014, The Journal of Biological Chemistry.

[19]  G. Remuzzi,et al.  Overview of Complement Activation and Regulation , 2013, Seminars in nephrology.

[20]  J. Chodosh,et al.  The Genetics of Keratoconus , 2013, Seminars in ophthalmology.

[21]  Sundaram Natarajan,et al.  Keratoconus , 2013, Indian journal of ophthalmology.

[22]  A. Pandey,et al.  The keratoconus corneal proteome: loss of epithelial integrity and stromal degeneration. , 2013, Journal of proteomics.

[23]  G. Snibson,et al.  Localized changes in stromal reflectivity after corneal collagen cross-linking observed with different imaging techniques. , 2013, Journal of refractive surgery.

[24]  J. Denton,et al.  An in depth analysis of histopathological characteristics found in keratoconus , 2012, Pathology.

[25]  Craig Boote,et al.  Depth profile study of abnormal collagen orientation in keratoconus corneas. , 2012, Archives of ophthalmology.

[26]  F. J. Romero,et al.  Oxidative stress in keratoconus? , 2011, Investigative ophthalmology & visual science.

[27]  R. Joseph,et al.  Differential epithelial and stromal protein profiles in keratoconus and normal human corneas. , 2011, Experimental eye research.

[28]  Caroline L. Speck,et al.  Subnormal Cytokine Profile in the Tear Fluid of Keratoconus Patients , 2011, PloS one.

[29]  J. Hassell,et al.  The molecular basis of corneal transparency. , 2010, Experimental eye research.

[30]  M. Madigan,et al.  Secreted frizzled‐related protein 1 (SFRP1) is highly upregulated in keratoconus epithelium: a novel finding highlighting a new potential focus for keratoconus research and treatment , 2010, Clinical & experimental ophthalmology.

[31]  Ying Chen,et al.  Antioxidant defenses in the ocular surface. , 2009, The ocular surface.

[32]  C. Ng,et al.  APM2 is a novel mediator of cisplatin resistance in a variety of cancer cell types regardless of p53 or MMR status , 2009, International journal of cancer.

[33]  Hsin-Ping Liu,et al.  A novel genetic variant of BMP2K contributes to high myopia , 2009, Journal of clinical laboratory analysis.

[34]  I. Lema,et al.  Inflammatory Response to Contact Lenses in Patients With Keratoconus Compared With Myopic Subjects , 2008, Cornea.

[35]  T. Foster,et al.  Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1. , 2008, Experimental eye research.

[36]  V. Vasiliou,et al.  The role of corneal crystallins in the cellular defense mechanisms against oxidative stress. , 2008, Seminars in cell & developmental biology.

[37]  C. McGhee,et al.  The Dundee University Scottish Keratoconus study: demographics, corneal signs, associated diseases, and eye rubbing , 2008, Eye.

[38]  Nathan Efron,et al.  New perspectives on keratoconus as revealed by corneal confocal microscopy , 2008, Clinical & experimental optometry.

[39]  S. Marklund,et al.  Interleukin-1alpha downregulates extracellular-superoxide dismutase in human corneal keratoconus stromal cells. , 2007, Molecular vision.

[40]  M. Mann,et al.  Parts per Million Mass Accuracy on an Orbitrap Mass Spectrometer via Lock Mass Injection into a C-trap*S , 2005, Molecular & Cellular Proteomics.

[41]  Nathan Efron,et al.  In vivo corneal confocal microscopy in keratoconus , 2005, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[42]  I. Lema,et al.  Inflammatory molecules in the tears of patients with keratoconus. , 2005, Ophthalmology.

[43]  V. Vasiliou,et al.  Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. , 2005, Investigative ophthalmology & visual science.

[44]  R. Burgeson,et al.  A Novel Marker of Tissue Junctions, Collagen XXII* , 2004, Journal of Biological Chemistry.

[45]  Xing Wang Deng,et al.  The COP9 signalosome. , 2003, Annual review of cell and developmental biology.

[46]  Donald J. Brown,et al.  The cascade hypothesis of keratoconus. , 2003, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[47]  T. Seiler,et al.  Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. , 2003, American journal of ophthalmology.

[48]  Adam Smith Protein misfolding , 2003, Nature.

[49]  D. Ron,et al.  Translational control in the endoplasmic reticulum stress response. , 2002, The Journal of clinical investigation.

[50]  M. Franceschi,et al.  Protein misfolding in Alzheimer’s and Parkinson’s disease: genetics and molecular mechanisms , 2002, Neurobiology of Aging.

[51]  S. Marklund,et al.  Superoxide dismutase isoenzymes in the normal and diseased human cornea. , 2001, Investigative ophthalmology & visual science.

[52]  J. Sugar,et al.  Expression of type XII collagen and hemidesmosome-associated proteins in keratoconus corneas , 2001, Current eye research.

[53]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[54]  M. Kenney,et al.  Everett Kinsey lecture. The elusive causes of keratoconus: a working hypothesis. , 2000, The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc.

[55]  J. Ruckhofer,et al.  Intacs: The Intrastromal Corneal Ring , 2000, International ophthalmology clinics.

[56]  Mold,et al.  Mechanism of complement‐dependent haemolysis via the lectin pathway: role of the complement regulatory proteins , 1999, Clinical and experimental immunology.

[57]  T T McMahon,et al.  Baseline findings in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. , 1998, Investigative ophthalmology & visual science.

[58]  M. Macsai,et al.  Development of keratoconus after contact lens wear. Patient characteristics. , 1990, Archives of ophthalmology.

[59]  J. Krachmer,et al.  Keratoconus and related noninflammatory corneal thinning disorders. , 1984, Survey of ophthalmology.

[60]  B. Mondino,et al.  Hemolytic complement activity in normal human donor corneas. , 1980, Archives of ophthalmology.

[61]  R. Stroud,et al.  Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator. , 1980, Journal of immunology.

[62]  S. I. Brown,et al.  Alternate and classical pathway components of complement in the normal cornea. , 1980, A M A Archives of Ophthalmology.

[63]  V. Nussenzweig,et al.  Human C4-binding protein. II. Role in proteolysis of C4b by C3b- inactivator , 1978, The Journal of experimental medicine.

[64]  V. Nussenzweig,et al.  Human C4-binding protein. I. Isolation and characterization , 1978, The Journal of experimental medicine.